XML 55 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Segments of Business and Geographic Areas
6 Months Ended
Jun. 29, 2014
Segment Reporting [Abstract]  
SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS
SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS

SALES BY SEGMENT OF BUSINESS
 
 
Fiscal Second Quarters Ended
(Dollars in Millions)
 
June 29,
2014
 
June 30,
2013
 
Percent
Change
 
 
 
 
 
 
 
Consumer
 
 
 
 
 
 
United States
 
$
1,320

 
1,326

 
(0.5
)%
International
 
2,424

 
2,332

 
3.9

Total
 
3,744

 
3,658

 
2.4

Pharmaceutical
 
 
 
 
 
 
United States
 
4,613

 
3,377

 
36.6

International
 
3,896

 
3,648

 
6.8

Total
 
8,509

 
7,025

 
21.1

Medical Devices & Diagnostics
 
 
 
 
 
 
United States
 
3,199

 
3,243

 
(1.4
)
International
 
4,043

 
3,951

 
2.3

Total
 
7,242

 
7,194

 
0.7

Worldwide
 
 
 
 
 
 
United States
 
9,132

 
7,946

 
14.9

International
 
10,363

 
9,931

 
4.4

Total
 
$
19,495

 
17,877

 
9.1
 %

 
 
 
 
 
 
 
 
 
Fiscal Six Months Ended
(Dollars in Millions)
 
June 29,
2014
 
June 30,
2013
 
Percent
Change
 
 
 
 
 
 
 
Consumer
 
 
 
 
 
 
United States
 
$
2,629

 
2,674

 
(1.7
)%
International
 
4,672

 
4,659

 
0.3

Total
 
7,301

 
7,333

 
(0.4
)
Pharmaceutical
 
 
 
 
 
 
United States
 
8,353

 
6,848

 
22.0

International
 
7,654

 
6,945

 
10.2

Total
 
16,007

 
13,793

 
16.1

Medical Devices & Diagnostics
 
 
 
 
 
 
United States
 
6,354

 
6,449

 
(1.5
)
International
 
7,948

 
7,807

 
1.8

Total
 
14,302

 
14,256

 
0.3

Worldwide
 
 
 
 
 
 
United States
 
17,336

 
15,971

 
8.5

International
 
20,274

 
19,411

 
4.4

Total
 
$
37,610

 
35,382

 
6.3
 %

SEGMENT PRE-TAX PROFIT
 
 
Fiscal Second Quarters Ended
(Dollars in Millions)
 
June 29,
2014
 
June 30,
2013
 
Percent
Change
Consumer(1)
 
$
703

 
511

 
37.6
%
Pharmaceutical (2)
 
3,469

 
2,992

 
15.9

Medical Devices & Diagnostics(3)
 
1,703

 
1,517

 
12.3

Segments operating profit
 
5,875

 
5,020

 
17.0

Less: Expense not allocated to segments(4)
 
249

 
227

 
 
Worldwide income before taxes
 
$
5,626

 
4,793

 
17.4
%

 
 
 
 
 
 
 
 
 
Fiscal Six Months Ended
(Dollars in Millions)
 
June 29, 2014
 
June 30, 2013
 
Percent
Change
Consumer (1)
 
$
1,181

 
1,058

 
11.6
%
Pharmaceutical (2)
 
6,674

 
5,409

 
23.4

Medical Devices & Diagnostics (3)
 
3,670

 
3,035

 
20.9

Segments operating profit
 
11,525

 
9,502

 
21.3

Less: Expense not allocated to segments (4)
 
475

 
448

 
 
Worldwide income before taxes
 
$
11,050

 
9,054

 
22.0
%

(1) Includes a gain of $332 million from the divestiture of the K-Y® brand recorded in the fiscal second quarter and first fiscal six months of 2014. Includes a gain on the sale of intangible and other assets of $55 million recorded in the first fiscal six months of 2013.
(2) Includes litigation expense of $178 million recorded in the first fiscal six months of 2013 and a net gain of $420 million on equity investment transactions, primarily the sale of Elan American Depositary Shares, in the fiscal second quarter and first fiscal six months of 2013.
(3) Includes Synthes integration/transaction costs of $144 million, litigation expense of $276 million and an in-process research and development charge of $4 million recorded in the fiscal second quarter of 2014. Includes Synthes integration/transaction costs of $122 million, litigation expense of $375 million and $69 million for costs associated with the ASRTM Hip program recorded in the fiscal second quarter of 2013.
Includes Synthes integration/transaction costs of $262 million, litigation expense of $276 million and an in-process research and development charge of $22 million recorded in the first fiscal six months of 2014. Includes Synthes integration/transaction costs of $380 million, litigation expense of $720 million, an in-process research and development charge of $64 million and $82 million for costs associated with the ASRTM Hip program recorded in the first fiscal six months of 2013.
(4) Amounts not allocated to segments include interest income/expense, noncontrolling interests and general corporate income/expense. The first fiscal six months of 2013 includes litigation expense of $6 million.
SALES BY GEOGRAPHIC AREA
 
 
Fiscal Second Quarters Ended
(Dollars in Millions)
 
June 29, 2014
 
June 30, 2013
 
Percent
Change
United States
 
$
9,132

 
7,946

 
14.9
 %
Europe
 
5,056

 
4,672

 
8.2

Western Hemisphere, excluding U.S.
 
1,863

 
1,905

 
(2.2
)
Asia-Pacific, Africa
 
3,444

 
3,354

 
2.7

Total
 
$
19,495

 
17,877

 
9.1
 %

 
 
 
 
 
 
 
 
 
Fiscal Six Months Ended
(Dollars in Millions)
 
June 29, 2014
 
June 30, 2013
 
Percent
Change
United States
 
$
17,336

 
15,971

 
8.5
 %
Europe
 
9,941

 
9,153

 
8.6

Western Hemisphere, excluding U.S.
 
3,558

 
3,688

 
(3.5
)
Asia-Pacific, Africa
 
6,775

 
6,570

 
3.1

Total
 
$
37,610

 
35,382

 
6.3
 %